In this second of two podcasts, Pete Piliero, MD, VP & Head, Medical Affairs Americas, GSK Consumer Healthcare, moderates a discussion on Global/Regional/Local Planning; Approach to MA Strategic Planning - Rare Disease & Oncology; and, Compliance Considerations.
Panelists are:
- Tina Beaman, VP and Chief Compliance Officer, Karyopharm Therapeutics
- Ed Gudaitis, President & CEO Acerus Pharma
- Keith Johns, VP, Global Marketing and Alliance Management, Eli Lilly & Co
- Maria Rivas, Chief Medical Officer, EMD Serono/Merck KGaA